BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC)

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, par value $0.004 per share ("Shares")
Shares outstanding: 22,866,677
Number of holders: 15
Total 13F shares, excl. options: 6,287,737
Shares change: +276,483
Total reported value, excl. options: $98,861,000
Value change: +$4,298,929
Number of buys: 6
Number of sells: -3
Price: $15.74

Significant Holders of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) as of Q2 2020

16 filings reported holding BCYC - BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") as of Q2 2020.
BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 6,287,737 shares of 22,866,677 outstanding shares and own 27.5% of the company stock.
Largest 10 shareholders include TYBOURNE CAPITAL MANAGEMENT (HK) LTD (1,957,961 shares), SV Health Investors, LLC (1,915,274 shares), Atlas Venture Advisors, Inc. (1,362,696 shares), Point72 Asset Management, L.P. (400,499 shares), FMR LLC (211,444 shares), VICTORY CAPITAL MANAGEMENT INC (207,583 shares), RENAISSANCE TECHNOLOGIES LLC (74,700 shares), Laurion Capital Management LP (57,892 shares), ADVISOR GROUP HOLDINGS, INC. (34,000 shares), and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (18,745 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.